17 alpha-hydroxyprogesterone caproate has been researched along with non-ovlon in 1 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (non-ovlon) | Trials (non-ovlon) | Recent Studies (post-2010) (non-ovlon) |
---|---|---|---|---|---|
517 | 88 | 251 | 25 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bokhman, IaV; Tkeshelashvili, VT; VishnevskiÄ, AS | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and non-ovlon
Article | Year |
---|---|
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |